The AK-OTOF therapy remains in early-stage clinical testing, but the success in the first patient to receive it – an 11-year-old boy who was profoundly deaf, but whose hearing is now reported to ...

Akouos and Lilly, meanwhile, said at last year's ARO conference that their AK-TOF improved hearing in a single 11-year-old subject in the phase 1/2 AK-OTOF-101 trial.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.